MA52150A - Compositions et procédés faisant intervenir des molécules probiotiques - Google Patents

Compositions et procédés faisant intervenir des molécules probiotiques

Info

Publication number
MA52150A
MA52150A MA052150A MA52150A MA52150A MA 52150 A MA52150 A MA 52150A MA 052150 A MA052150 A MA 052150A MA 52150 A MA52150 A MA 52150A MA 52150 A MA52150 A MA 52150A
Authority
MA
Morocco
Prior art keywords
compositions
processes involving
probiotic molecules
probiotic
molecules
Prior art date
Application number
MA052150A
Other languages
English (en)
Inventor
Monica Angela Cella
Sarah M Curtis
Jonathon Patrick Roepke
Original Assignee
Microsintesis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microsintesis Inc filed Critical Microsintesis Inc
Publication of MA52150A publication Critical patent/MA52150A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/195Proteins from microorganisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/46Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/335Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/25Peptides having up to 20 amino acids in a defined sequence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404Biocides, antimicrobial agents, antiseptic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Materials Engineering (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MA052150A 2017-03-16 2018-03-16 Compositions et procédés faisant intervenir des molécules probiotiques MA52150A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762472047P 2017-03-16 2017-03-16

Publications (1)

Publication Number Publication Date
MA52150A true MA52150A (fr) 2020-01-22

Family

ID=63522209

Family Applications (1)

Application Number Title Priority Date Filing Date
MA052150A MA52150A (fr) 2017-03-16 2018-03-16 Compositions et procédés faisant intervenir des molécules probiotiques

Country Status (16)

Country Link
US (2) US20200016290A1 (fr)
EP (1) EP3596103A4 (fr)
JP (1) JP7252145B2 (fr)
KR (1) KR20190141667A (fr)
CN (1) CN110621689B (fr)
AU (2) AU2018233588A1 (fr)
BR (1) BR112019019255A2 (fr)
CA (1) CA3056718A1 (fr)
CL (1) CL2019002641A1 (fr)
EA (1) EA201992175A1 (fr)
MA (1) MA52150A (fr)
MX (1) MX2019011060A (fr)
PE (1) PE20191785A1 (fr)
PH (1) PH12019502341A1 (fr)
SG (1) SG11201909602TA (fr)
WO (1) WO2018165764A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11912788B2 (en) 2017-03-16 2024-02-27 Microsintesis Inc. Probiotic molecules for reducing pathogen virulence
KR102135195B1 (ko) * 2018-10-08 2020-07-17 아주대학교산학협력단 테트라제노코커스 할로필러스를 포함하는 베체트병 또는 헤르페스 바이러스 감염증의 예방 또는 치료용 조성물
BR112022000041A2 (pt) * 2019-07-02 2022-03-15 Microsintesis Inc Inibidores de detecção de quorum e / ou metabólitos pósbióticos e métodos relacionados
CN112980712A (zh) * 2019-12-14 2021-06-18 山东大学 一种调节高原人群情绪及肠道菌群稳定的微生物组合物及其应用
CN114591879B (zh) * 2022-05-11 2022-12-06 中国农业大学 一种抑制幽门螺杆菌的发酵乳杆菌及其应用
KR102551065B1 (ko) * 2022-05-12 2023-07-03 중앙대학교 산학협력단 김치로부터 유래된 LAB(lactic acid bacteria)을 유효성분으로 포함하는 항-바이오필름 조성물
WO2024097250A1 (fr) * 2022-10-31 2024-05-10 The Trustees Of Columbia University In The City Of New York Support polymère pour probiotiques
CN117815160B (zh) * 2023-11-08 2024-05-28 首都医科大学附属北京潞河医院 一种黄芪散饮片的制备及其在治疗慢性肾功能不全中的应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0395309B1 (fr) * 1989-04-28 1995-12-27 Takara Shuzo Co. Ltd. Polypeptide semblable à la calpastatine humaine
FR2686085B1 (fr) * 1992-01-10 1995-08-04 Agronomique Inst Nat Rech Peptides representant des fragments du cmp, anticorps diriges contre lesdits peptides, et leurs utilisations.
WO1994018832A1 (fr) * 1993-02-26 1994-09-01 Dana-Farber Cancer Institute, Inc. Modulation a mediation cd4 de kinases lipidiques
US7393663B2 (en) * 1997-08-01 2008-07-01 Serono Genetics Institute S.A. Expressed sequence tags and encoded human proteins
US20040031072A1 (en) * 1999-05-06 2004-02-12 La Rosa Thomas J. Soy nucleic acid molecules and other molecules associated with transcription plants and uses thereof for plant improvement
ES2381118T3 (es) * 2004-12-23 2012-05-23 Campina Nederland Holding B.V. Hidrolizado de proteínas enriquecido en péptidos de inhibición de DPP-IV y su uso
WO2007038876A1 (fr) * 2005-10-04 2007-04-12 Inimex Pharmaceuticals Inc. Nouveaux peptides destines au traitement et a la prevention de troubles lies a l'immunite, y compris au traitement et a la prevention de l'infection par modulation de l'immunite innee
JP2009516738A (ja) * 2005-11-21 2009-04-23 ティーガスク−ザ アグリカルチャー アンド フード デベロップメント オーソリティー カゼイン由来の抗菌ペプチドおよびそれを生成するLactobacillus株
US8431528B2 (en) * 2008-05-16 2013-04-30 University Of Maryland, Baltimore Antibacterial Lactobacillus GG peptides and methods of use
EP2307444B1 (fr) * 2008-06-27 2021-12-08 University Of Guelph Analyse des molécules d'interférence du signal de lactobacillus acidophilus la-5
US8758765B2 (en) * 2008-07-29 2014-06-24 The University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
GB201001602D0 (en) * 2010-02-01 2010-03-17 Cytovation As Oligopeptidic compounds and uses therof
EP2550529B1 (fr) * 2010-03-23 2021-11-17 Iogenetics, LLC. Procédés bioinformatiques pour déterminer la liaison de peptides
WO2014035345A1 (fr) * 2012-08-29 2014-03-06 Agency For Science, Technology And Research Peptides et utilisations associées
US9637523B2 (en) * 2012-08-31 2017-05-02 Westfaelische Wilhelms-Universitaet Muenster Methods and peptides for preventing and treating a BCR-ABL and a C-ABL associated disease
US9539223B2 (en) * 2013-05-01 2017-01-10 Neoculi Pty Ltd Methods for treating bacterial infections
CA2923982A1 (fr) * 2013-08-12 2015-02-19 Mansel Griffiths Methodes et compositions antivirales comprenant des molecules bacteriennes probiotiques
JP6262694B2 (ja) * 2014-08-18 2018-01-17 森永乳業株式会社 プロリルオリゴペプチダーゼ阻害剤
EP3286361A4 (fr) * 2015-04-23 2019-05-08 Nantomics, LLC Néo-épitopes de cancer
US11912788B2 (en) * 2017-03-16 2024-02-27 Microsintesis Inc. Probiotic molecules for reducing pathogen virulence

Also Published As

Publication number Publication date
SG11201909602TA (en) 2019-11-28
CN110621689A (zh) 2019-12-27
PH12019502341A1 (en) 2020-10-12
WO2018165764A1 (fr) 2018-09-20
KR20190141667A (ko) 2019-12-24
CA3056718A1 (fr) 2018-09-20
AU2022202600A1 (en) 2022-05-12
AU2022202600B2 (en) 2024-01-04
CL2019002641A1 (es) 2020-05-15
EA201992175A1 (ru) 2020-03-05
PE20191785A1 (es) 2019-12-24
AU2018233588A1 (en) 2019-10-31
BR112019019255A2 (pt) 2020-04-14
JP7252145B2 (ja) 2023-04-04
US20240016970A1 (en) 2024-01-18
US20200016290A1 (en) 2020-01-16
EP3596103A4 (fr) 2021-01-20
MX2019011060A (es) 2019-12-09
EP3596103A1 (fr) 2020-01-22
JP2020510095A (ja) 2020-04-02
CN110621689B (zh) 2024-04-16

Similar Documents

Publication Publication Date Title
MA52150A (fr) Compositions et procédés faisant intervenir des molécules probiotiques
IL287586A (en) Methods and preparations for enriching breeding products
MA46427A (fr) Compositions d'oligonucléotides et procédés associés
MA43380A (fr) Récepteurs chimériques modifiés et compositions et procédés associés
MA45779A (fr) Polypeptides immunomdulateurs et compositions et procédés associés
IL313163A (en) Multispecific antigen binding molecules and their uses
SG10202100951SA (en) Chemical compositions and methods of using same
DK3303265T3 (da) Sammensætning indeholdende n-(n-butyl)-thiophosphortriamid-additionsprodukter og reaktionsprodukter
DK3443009T3 (da) Anti-tim-3-antistoffer og sammensætninger
DK3302431T3 (da) Taxanpartikler og anvendelse deraf
MA50569A (fr) Ensembles de remplissage-finition et procédés associés
MA41558A (fr) Compositions d'allergènes mélangés et leurs procédés d'utilisation
MA45270A (fr) Compositions d'oligonucléotides et procédés associés
ZA201803451B (en) Probiotic compositions and uses thereof
DK3189081T3 (da) Cd123-bindende midler og anvendelser deraf
DK3116909T3 (da) Antistofmolekyler til lag-3 og anvendelser deraf
EP3551688C0 (fr) Composites conducteurs d'ions microstructurés et leurs utilisations
MA41863A (fr) Compositions et procédés permettant de traiter une anémie
MA47613A (fr) Compositions et procédés de traitement du cancer
HK1248721A1 (zh) 抗體分子及其用途
DK3194564T3 (da) Trichodermasammensætninger og anvendelsesfremgangsmåder
MA46543A (fr) Variants de l'endonucléase tgfbéta r2, compositions et procédés d'utilisation
DK3209307T3 (da) Probiotiske og præbiotiske sammensætninger
IL284242A (en) Gingerpine lysine suppressants, preparations containing them and their uses
DK3417058T3 (da) Sortase-modificerede molekyler og anvendelser deraf